AMAM - Ambrx Biopharma falls after Phase 1/2 data for prostate cancer therapy October, 23 2023 11:04 AM Ambrx Biopharma Inc. American Depositary Shares (each representing seven) 2023-10-23 11:04:06 ET More on Ambrx Biopharma Promising Developments In Ambrx's Engineered Precision Biologics Historical earnings data for Ambrx Biopharma Financial information for Ambrx Biopharma For further details see: Ambrx Biopharma falls after Phase 1/2 data for prostate cancer therapy